(Total Views: 628)
Posted On: 07/14/2023 11:29:25 AM
Post# of 156838
"That money would be better used for ongoing expenses and the NASH trial."
Amen to that! We need Leronlimab back in play! This molecule can't do any good, if it is not proving itself worthy. Of course that goes for the company as well.
Read More: https://investorshangout.com/post/newpost/605...z87S61iwk8
Amen to that! We need Leronlimab back in play! This molecule can't do any good, if it is not proving itself worthy. Of course that goes for the company as well.
Read More: https://investorshangout.com/post/newpost/605...z87S61iwk8
(1)
(0)
